Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Urologic Lymphadenectomy in AMIGO

NCT: NCT05132283 · RECRUITING

NCT IDNCT05132283
StatusRECRUITING
Start Date2022-04-01
Completion2026-09-01
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

This research study involves the use of two navigation systems, the 3D Slicer-based navigation system, and the Siemens Monaco systems, to simplify the complexity of image-guided lymphadenectomy procedures (surgery to remove one or more lymph nodes) in patients with urological cancer.

Frequently Asked Questions

What is Urologic Lymphadenectomy in AMIGO?

Urologic Lymphadenectomy in AMIGO is a clinical trial registered under NCT05132283. Current status: RECRUITING.

What is the status of NCT05132283?

The current status of NCT05132283 (Urologic Lymphadenectomy in AMIGO) is: RECRUITING.

When did Urologic Lymphadenectomy in AMIGO start?

Urologic Lymphadenectomy in AMIGO started on 2022-04-01.

Related Devices

K192703Cranial Image Guided Surgery System, Navigation Software Cranial, Navigation Software ENT, Registration Software Cranial, Automatic Registration 2.0, Ultrasound Navigation Software (BK), Intraoperative Structure UpdateBrainlab AG K243053Navient Image Guided Navigation System (ENT) (955-NC-NC)Claronav

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑